局部进展期胰腺癌治疗新进展-2009CSCO年会精选.pptVIP

可切除(resectable) T1-2 (OP w/o adjuvant) T1-2 (OP + Adjuvant CT) T3-4 (OP w/o adjuvant) T3-4 (OP + Adjuvant CT) 局部晚期(locally advanced) Borderline resectable (Neo-adjuvant + OP) 無法切除(unresectable) (Neo-adjuvant + OP) (ICT + CCRT) (Gem-based CT) (CCRT + CT) 轉移性(metastatic) // I I I I I I 5 10 15 20 25 30 27.6 19.1 50.2 20.5 14.0 14.3 18.0 20.5 13.0 11.0 7.0 ITT Per protocol Our data suggested inductional chemotherapy followed by CCRT could achieve encouraging survival in unresectable LAPC Role in earlier stag